| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/09/1996 | US5534268 Liposomes containing bioavailable iron (II) and process for obtaining them |
| 07/09/1996 | US5534260 Transdermal drug delivery, occlusion of skin, removal of occlusion and applying drug to skin |
| 07/09/1996 | US5534251 Stabilized il-1α medicinal composition |
| 07/09/1996 | US5534250 Polymers containing diester units |
| 07/09/1996 | CA1338438C Pharmaceutical composition |
| 07/06/1996 | CA2166527A1 Topical pharmaceutical compositions |
| 07/04/1996 | WO1996020236A1 Polyglycomers |
| 07/04/1996 | WO1996020222A1 Novel cyclodextrin-derivatives and methods for the preparation thereof |
| 07/04/1996 | WO1996020208A2 New cholesterol derivative for liposomal gene transfer |
| 07/04/1996 | WO1996020012A2 Methods for preparing and purifying macromolecular conjugates |
| 07/04/1996 | WO1996020011A1 Chemical compounds |
| 07/04/1996 | WO1996020008A1 Vaccine adjuvants |
| 07/04/1996 | WO1996020005A1 Protracted glp-1 compositions |
| 07/04/1996 | WO1996020001A1 Transmucosal preparation |
| 07/04/1996 | WO1996019975A1 Transdermal resorption of active substances from supercooled masses |
| 07/04/1996 | WO1996019970A1 Hemolysis prevention by surfactants and emulsions |
| 07/04/1996 | WO1996019969A1 Stable budesonide solutions, method of preparing them and use of these solutions as enema preparations and pharmaceutical foams |
| 07/04/1996 | WO1996019968A1 Pharmaceutical aerosol containing at least one sugar |
| 07/04/1996 | WO1996019956A1 Transdermal administration of apomorphine |
| 07/04/1996 | DE4446937A1 New substd. carbamoyl-cholesterol deriv. |
| 07/04/1996 | DE4446891A1 Stabile wäßrige Budesonid-Lösung Stable aqueous budesonide solution |
| 07/04/1996 | CA2209016A1 Pharmaceutics for mucosal administration |
| 07/04/1996 | CA2205091A1 Chemical compounds |
| 07/03/1996 | EP0719561A1 Percutaneously absorbable preparation |
| 07/03/1996 | EP0719549A1 Soft gelatine pharmaceutical dosage form containing a translucent gel |
| 07/03/1996 | EP0719548A1 Gelling agent for polyethylene glycol |
| 07/03/1996 | EP0719546A1 LUV comprising saturated phospholipids and method of making the same |
| 07/03/1996 | EP0719545A1 Thermally reversible and irreversible gels |
| 07/03/1996 | EP0719540A1 Cosmetic or dermatological water-in-oil emulsion with high hydroxyacids content |
| 07/03/1996 | EP0719343A1 Adeno-associated viral (aav) liposomes and methods related thereto |
| 07/03/1996 | EP0719295A1 Polymeric matrices and their uses in pharmaceutical compositions |
| 07/03/1996 | EP0719286A1 Dextran esters, process for producing them and their use for encasing and encapsulating medicaments |
| 07/03/1996 | EP0719153A1 Inhibition of heparin-binding |
| 07/03/1996 | EP0719146A1 Novel method of progesterone delivery and affect thereof |
| 07/03/1996 | EP0719128A1 Composition containing phosphate derivatives |
| 07/03/1996 | EP0669836B1 Therapeutic application of chimeric and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen for treatment of b cell lymphoma |
| 07/03/1996 | EP0472598B1 Dry powder inhalation device |
| 07/03/1996 | CN1032190C Method for reducing side effects of drug |
| 07/02/1996 | US5532305 Hyaluronic acid and cationic polyacrylic acid copolymer for time release agents |
| 07/02/1996 | US5532274 Levodopa, carbidopa, vinyl acetate-vinyl alcohol copolymer |
| 07/02/1996 | US5532150 Immobilized superoxide dismutase |
| 07/02/1996 | US5532009 Complex with a cyclodextrin; bioavailability; foods, drugs |
| 07/02/1996 | US5532000 Aqueous cosmetic or dermo-pharmaceutical composition containing, in suspension, hydrated spheroids of a hydrophilic lipidic substance |
| 07/02/1996 | US5531980 Stable microbubbles suspensions injectable into living organisms |
| 07/02/1996 | US5531978 Aminopolycarboxylic acids and derivatives thereof |
| 07/02/1996 | US5531735 Medical devices containing triggerable disintegration agents |
| 07/02/1996 | US5531219 Use of liquid fluorocarbons to facilitate pulmonary drug delivery |
| 06/27/1996 | WO1996019246A1 Continuous low-dose administration of parathyroid hormone or its agonist |
| 06/27/1996 | WO1996019242A1 Complexes of dermatan sulfate and drugs, giving improved pharmacokinetics |
| 06/27/1996 | WO1996019241A1 Targeting complexes and use thereof |
| 06/27/1996 | WO1996019240A1 Oligonucleotide-dendrimer conjugates |
| 06/27/1996 | WO1996019230A1 Soluble 2-chloro-2'-deoxyadenosine formulations |
| 06/27/1996 | WO1996019229A1 Stable solutions of 2-chloro-2'-deoxyadenosine formulations |
| 06/27/1996 | WO1996019228A1 Formulations and methods for reducing skin irritation |
| 06/27/1996 | WO1996019209A1 Chalcones and esters thereof with antiproliferative activity in uterus, ovary and breast tumours |
| 06/27/1996 | WO1996019207A1 Powder formulations containing melezitose as a diluent |
| 06/27/1996 | WO1996019206A1 Therapeutic preparation for inhalation containing parathyroïd hormone, pth |
| 06/27/1996 | WO1996019199A1 Proliposome powders for inhalation |
| 06/27/1996 | WO1996019198A1 Aerosol drug formulations |
| 06/27/1996 | WO1996019197A1 Aerosol formulations of peptides and proteins |
| 06/27/1996 | WO1996019186A1 Antifungal treatment of nails |
| 06/27/1996 | WO1996019184A1 Formulations and methods for reducing skin irritation |
| 06/27/1996 | WO1996019183A1 Formulations and methods for reducing skin irritation |
| 06/27/1996 | WO1996019119A1 Silicone compositions |
| 06/27/1996 | WO1996015786A3 Oral compositions containing ondansetron |
| 06/27/1996 | WO1996012190A3 Presentation of hydrophobic antigens to t-cells by cd1 molecules |
| 06/27/1996 | DE4446600A1 Transdermale Resorption von Wirkstoffen aus unterkühlten Schmelzen Transdermal absorption of drugs from undercooled melts |
| 06/27/1996 | CA2208566A1 Complexes of dermatan sulfate and drugs, giving improved pharmacokinetics |
| 06/27/1996 | CA2208517A1 Proliposome powders for inhalation |
| 06/27/1996 | CA2208268A1 Formulations and methods for reducing skin irritation |
| 06/27/1996 | CA2208088A1 Antifungal treatment of nails |
| 06/27/1996 | CA2206915A1 Oligonucleotide-dendrimer conjugates |
| 06/27/1996 | CA2206803A1 Powder formulations containing melezitose as a diluent |
| 06/27/1996 | CA2205959A1 Continuous low-dose administration of parathyroid hormone or its agonist |
| 06/26/1996 | EP0718312A2 Crosslinked acidic polysaccharides and their uses |
| 06/26/1996 | EP0717999A1 Drug delivery composition |
| 06/26/1996 | EP0717987A2 Suspension aerosol formulations |
| 06/26/1996 | EP0717753A1 Ribosome inactivating proteins extracted from seeds of saponaria ocymoides and vaccaria pyramidata, their preparation and immunotoxins containing them |
| 06/26/1996 | EP0717638A1 Improved pharmaceutical formulation |
| 06/26/1996 | EP0717637A1 Inclusion complexes of beta-cyclodextrin with flurbiprofen, ketoprofen and naproxen |
| 06/26/1996 | EP0717633A1 Growth differentiation factor-7 |
| 06/26/1996 | EP0717618A1 Stabilized tablet formulation |
| 06/26/1996 | EP0717616A1 Process for conditioning substances |
| 06/26/1996 | EP0697859A4 Stable, ingestable and absorbable nadh and nadph therapeutic compositions |
| 06/26/1996 | EP0696201A4 Supplemented and unsupplemented tissue sealants, methods of their production and use |
| 06/26/1996 | EP0660714A4 Novel liposomal drug delivery systems. |
| 06/26/1996 | EP0616508A4 Gas filled liposomes and their use as ultrasonic contrast agents. |
| 06/26/1996 | EP0474642B1 Chelants |
| 06/26/1996 | EP0464135B1 Composition for reducing side effects of a drug |
| 06/26/1996 | CN1125452A Cellulose binding domain |
| 06/26/1996 | CN1125396A Extended release, film-coated tablet of astemizole and pseudoephedrine |
| 06/26/1996 | CN1125395A Compressible enzyme powder |
| 06/26/1996 | CN1125394A Novel therapeutic drug delivery systems |
| 06/26/1996 | CN1125389A Methods of preparing gas and gaseous precursor-filled microspheres |
| 06/26/1996 | CN1125192A Apparatus and method for administering minerals |
| 06/25/1996 | US5530123 Antiviral and chemotherapeutical agent for cancer |
| 06/25/1996 | US5530006 Rapamycin formulation for IV injection |
| 06/25/1996 | US5529991 Oral 1α-hydroxyprevitamin D |
| 06/25/1996 | US5529986 Water soluble conjugate comprising biologically inert carrier having sulfated glycosaminoglycan molecules anchored to reactive groups thereon by covalent bonds so as to retain antithrombin-binding activity |
| 06/25/1996 | US5529922 Anti-idiotypic monoclonal antibody that induces an immune response against the ganglioside GD3 and hybridoma producing said antibody |